EYPT EBITDA | EyePoint, Inc.

EyePoint, Inc. (EYPT) EBITDA

2026-06-30: Basis Reported; EBITDA -$96.69M*; Operating income -$97.38M; Depreciation and amortization $690.00K*.
2026-03-31: Basis Reported; EBITDA -$86.59M; Operating income (m); Depreciation and amortization (m).
2025-09-30: Basis Reported; EBITDA (m); Operating income -$62.02M; Depreciation and amortization (m).
2025-06-30: Basis Reported; EBITDA -$61.69M*; Operating income -$62.23M; Depreciation and amortization $538.00K*.

Complete source-backed ebitda history.

Available history: 2024-12-31 to 2026-03-31
Data captured: 2026-09-04

Historical EBITDA

EBITDA 3 month

Date	Basis	EBITDA	Operating income	Depreciation and amortization	Revenue	EBITDA margin	Capital spending	Operating cash flow	Cost of products and services	Research and development	Selling, general and administration	Income tax expense / benefit
2026-06-30	Reported	-$96.69M*	-$97.38M	$690.00K*	$507.00K	-19071.01%*	$1.20M*	-$62.35M*	(m)	$83.61M	(m)	$0.00
2026-03-31	Reported	-$86.59M	(m)	(m)	(m)	-12441.09%	$997.00K	-$80.55M	(m)	$72.15M	(m)	-$50.00K
2025-09-30	Reported	(m)	-$62.02M	(m)	$966.00K	(m)	$798.00K*	-$59.35M*	(m)	$47.75M	(m)	$0.00
2025-06-30	Reported	-$61.69M*	-$62.23M	$538.00K*	$5.33M	-1156.74%*	$1.22M*	-$62.59M*	(m)	$55.50M	(m)	$93.00K
2025-03-31	Reported	-$48.34M	(m)	(m)	(m)	-197.69%	$276.00K	-$53.12M	(m)	$58.57M	(m)	$0.00
2024-09-30	Reported	(m)	-$32.75M	(m)	$10.52M	(m)	$1.57M*	-$39.03M*	$736.00K	$29.54M	(m)	$0.00
2024-06-30	Reported	(m)	-$34.55M	(m)	$9.48M	(m)	$900.00K*	-$20.18M*	$1.40M	$29.82M	(m)	$0.00
2024-03-31	Reported	(m)	-$33.32M	(m)	$11.68M	(m)	$1.19M	-$31.17M	$759.00K	$30.14M	(m)	(m)
2023-09-30	Reported	(m)	-$14.40M	(m)	$15.20M	(m)	$1.72M*	-$15.20M*	$1.20M	$17.36M	(m)	(m)
2023-06-30	Reported	(m)	-$22.76M	(m)	$9.11M	(m)	$396.00K*	$57.02M*	$1.79M	$15.73M	(m)	(m)
2023-03-31	Reported	(m)	-$21.55M	(m)	$7.68M	(m)	$484.00K	-$16.84M	$640.00K	$13.62M	(m)	(m)
2022-09-30	Reported	(m)	-$18.40M	(m)	$10.01M	(m)	$1.20M*	-$13.14M*	(m)	$11.16M	(m)	(m)
2022-06-30	Reported	(m)	-$19.22M	(m)	$11.56M	(m)	$218.00K*	-$19.12M*	(m)	$12.99M	(m)	(m)
2022-03-31	Reported	(m)	-$18.28M	(m)	$9.29M	(m)	$149.00K	-$20.16M	(m)	$9.95M	(m)	(m)
2021-09-30	Reported	(m)	-$15.31M	(m)	$9.06M	(m)	$131.00K*	-$7.79M*	(m)	$8.50M	(m)	(m)
2021-06-30	Reported	(m)	-$10.98M	(m)	$9.01M	(m)	$25.00K*	-$10.54M*	(m)	$5.61M	(m)	(m)
2021-03-31	Reported	(m)	-$10.94M	(m)	$7.32M	(m)	$0.00	-$15.10M	(m)	$5.48M	(m)	(m)
2020-09-30	Reported	(m)	-$1.96M	(m)	$15.70M	(m)	$128.00K*	$1.14M*	(m)	$4.09M	(m)	(m)
2020-06-30	Reported	(m)	-$11.15M	(m)	$4.12M	(m)	$26.00K*	-$5.12M*	(m)	$3.28M	(m)	(m)
2020-03-31	Reported	(m)	-$11.44M	(m)	$7.49M	(m)	$16.00K	-$16.34M	(m)	$4.85M	(m)	(m)
2019-12-31	Reported	(m)	-$8.98M	(m)	$8.63M	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2019-09-30	Reported	(m)	-$14.06M	(m)	$2.51M	(m)	$0.00*	-$14.77M*	(m)	$3.48M	(m)	(m)
2019-06-30	Reported	(m)	-$10.16M	(m)	$7.21M	(m)	$25.00K*	-$17.11M*	$706.00K	$3.96M	(m)	(m)
2019-03-31	Reported	(m)	-$14.65M	(m)	$2.01M	(m)	$182.00K	-$13.33M	$330.00K	$3.80M	(m)	(m)
2018-12-31	Reported	(m)	-$11.01M	(m)	$2.44M	(m)	$23.00K*	-$10.82M*	(m)	$4.18M*	(m)	$0.00*
2018-09-30	Reported	(m)	-$13.55M	(m)	$486.00K	(m)	$109.00K	-$11.77M	(m)	$6.23M	(m)	$0.00
2018-06-30	Reported	(m)	-$9.78M	(m)	$715.00K	(m)	(m)	-$6.08M*	$0.00	$4.76M	(m)	(m)
2018-03-31	Reported	(m)	-$4.68M	(m)	$928.00K	(m)	-$1.00K*	-$4.82M	(m)	$3.33M	(m)	$0.00
2017-12-31	Reported	(m)	-$5.81M	(m)	$933.00K	(m)	$0.00*	(m)	(m)	$4.27M	(m)	$0.00
2017-12-31	Reported	(m)	-$5.81M	(m)	$933.00K	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2017-09-30	Reported	(m)	-$6.01M	(m)	$385.00K	(m)	$64.00K	-$5.97M	(m)	$3.82M	(m)	$0.00
2017-06-30	Reported	(m)	-$6.14M	(m)	$701.00K	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2017-03-31	Reported	(m)	-$5.16M	(m)	$590.00K	(m)	$16.00K*	(m)	(m)	$3.32M	(m)	$0.00
2016-12-31	Reported	(m)	-$94.00K	(m)	$5.97M	(m)	$5.00K*	(m)	(m)	$3.17M	(m)	$0.00
2016-12-31	Reported	(m)	-$94.00K	(m)	$5.97M	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2016-09-30	Reported	(m)	-$7.19M	(m)	$277.00K	(m)	$0.00	(m)	(m)	$4.18M	(m)	$0.00
2016-06-30	Reported	(m)	-$6.46M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2016-03-31	Reported	(m)	-$5.10M	(m)	(m)	(m)	$31.00K*	(m)	(m)	$3.07M	(m)	-$34.00K
2015-12-31	Reported	(m)	-$5.24M	(m)	(m)	(m)	$25.00K*	(m)	(m)	$3.72M	(m)	-$42.00K
2015-09-30	Reported	(m)	-$4.98M	(m)	(m)	(m)	$11.00K	(m)	(m)	$3.48M	(m)	-$41.00K
2015-06-30	Reported	(m)	-$5.20M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2015-03-31	Reported	(m)	-$5.05M	(m)	(m)	(m)	$43.00K*	(m)	(m)	$3.34M	(m)	-$44.00K
2014-12-31	Reported	(m)	-$4.12M	(m)	(m)	(m)	$22.00K*	(m)	(m)	$2.77M	(m)	-$38.00K
2014-09-30	Reported	(m)	$20.79M	(m)	(m)	(m)	$6.00K	(m)	(m)	$2.78M	(m)	$226.00K
2014-06-30	Reported	(m)	-$4.01M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2014-03-31	Reported	(m)	-$2.22M	(m)	(m)	(m)	$54.00K*	(m)	(m)	$2.27M	(m)	-$31.00K
2013-12-31	Reported	(m)	-$3.54M	(m)	(m)	(m)	$13.00K*	-$2.26M*	(m)	$2.49M	(m)	-$26.00K
2013-09-30	Reported	(m)	-$3.72M	(m)	(m)	(m)	$8.00K	-$3.78M	(m)	$2.50M	(m)	-$30.00K
2013-06-30	Reported	(m)	-$3.98M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2013-03-31	Reported	(m)	-$2.81M	(m)	(m)	(m)	$13.00K*	-$1.96M*	(m)	$1.59M	(m)	-$15.00K
2012-12-31	Reported	(m)	-$2.65M	(m)	(m)	(m)	$32.00K*	-$1.78M*	(m)	$1.57M	(m)	-$37.00K
2012-09-30	Reported	(m)	-$2.59M	(m)	(m)	(m)	$4.00K	-$1.62M	(m)	$1.52M	(m)	-$33.00K
2012-06-30	Reported	(m)	-$2.31M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2012-03-31	Reported	(m)	-$2.73M	(m)	(m)	(m)	$19.00K*	-$2.14M*	(m)	$1.51M	(m)	-$30.00K
2011-12-31	Reported	(m)	-$17.64M	(m)	(m)	(m)	$159.00K*	-$2.36M*	(m)	$1.99M	(m)	-$44.00K
2011-09-30	Reported	(m)	-$2.53M	(m)	(m)	(m)	$221.00K	-$2.66M	(m)	$2.13M	(m)	$55.00K
2011-06-30	Reported	(m)	-$308.00K	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2011-03-31	Reported	(m)	-$3.14M	(m)	(m)	(m)	$9.00K*	-$1.61M*	(m)	$1.74M	(m)	-$113.00K
2010-12-31	Reported	(m)	-$3.12M	(m)	(m)	(m)	$50.00K*	-$583.00K*	(m)	$1.53M	(m)	$35.00K
2010-09-30	Reported	(m)	-$3.44M	(m)	(m)	(m)	$9.00K	-$2.22M	(m)	$1.74M	(m)	$9.00K

EBITDA 12 month

Date	Basis	EBITDA	Operating income	Depreciation and amortization	Revenue	EBITDA margin	Capital spending	Operating cash flow	Cost of products and services	Research and development	Selling, general and administration	Income tax expense / benefit
2025-12-31	Reported	-$241.13M	(m)	(m)	(m)	-768.62%	$3.28M	-$240.11M	(m)	$221.04M	(m)	$279.00K
2024-12-31	Reported	-$144.31M	(m)	(m)	(m)	-333.50%	$4.05M	-$126.23M	(m)	$132.93M	(m)	$90.00K
2023-12-31	Reported	(m)	-$75.07M	(m)	$46.02M	(m)	$3.48M	$1.88M	(m)	$64.66M	(m)	$83.00K
2022-12-31	Reported	(m)	-$99.64M	(m)	$41.40M	(m)	$2.15M	-$65.00M	(m)	$49.64M	(m)	$0.00
2021-12-31	Reported	(m)	-$55.28M	(m)	$36.94M	(m)	$156.00K	-$50.10M	(m)	$28.50M	(m)	$0.00
2020-12-31	Reported	(m)	-$37.29M	(m)	$34.44M	(m)	$362.00K	-$14.44M	(m)	$17.42M	(m)	$0.00
2020-09-30	Rolling	(m)	-$33.54M*	(m)	$35.94M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2020-06-30	Rolling	(m)	-$45.64M*	(m)	$22.75M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2020-03-31	Rolling	(m)	-$44.65M*	(m)	$25.84M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2019-12-31	Reported	(m)	-$47.86M	(m)	$20.36M	(m)	$213.00K	-$56.70M	(m)	$15.37M	(m)	$0.00
2019-12-31	Rolling	(m)	-$47.86M*	(m)	$20.36M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2019-09-30	Rolling	(m)	-$49.88M*	(m)	$14.17M*	(m)	$230.00K*	-$56.03M*	(m)	$15.41M*	(m)	(m)
2019-06-30	Rolling	(m)	-$49.38M*	(m)	$12.15M*	(m)	$339.00K*	-$53.03M*	(m)	$18.16M*	(m)	(m)
2019-03-31	Rolling	(m)	-$48.99M*	(m)	$5.66M*	(m)	(m)	-$42.00M*	(m)	$18.97M*	(m)	(m)
2018-12-31	Reported	(m)	-$39.02M	(m)	$4.57M	(m)	(m)	(m)	(m)	$18.50M	(m)	(m)
2018-12-31	Rolling	(m)	-$39.02M*	(m)	$4.57M*	(m)	(m)	-$33.49M*	(m)	$18.50M*	(m)	(m)
2018-06-30	Reported	(m)	-$26.27M	(m)	$2.96M	(m)	$108.00K	-$21.91M	(m)	$16.18M	(m)	$0.00
2017-06-30	Reported	(m)	-$18.58M	(m)	$7.54M	(m)	$147.00K	-$20.49M	(m)	$14.88M	(m)	$0.00
2016-09-30	Rolling	(m)	-$23.98M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2016-06-30	Reported	(m)	-$21.77M	(m)	$1.62M	(m)	$113.00K	-$16.32M	(m)	$14.38M	(m)	-$155.00K
2016-06-30	Rolling	(m)	-$21.77M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2016-03-31	Rolling	(m)	-$20.52M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2015-12-31	Rolling	(m)	-$20.47M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2015-09-30	Rolling	(m)	-$19.35M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2015-06-30	Reported	(m)	$6.42M	(m)	(m)	(m)	$161.00K	(m)	(m)	$12.09M	(m)	$96.00K
2015-06-30	Rolling	(m)	$6.42M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2015-03-31	Rolling	(m)	$7.61M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2014-12-31	Rolling	(m)	$10.44M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2014-09-30	Rolling	(m)	$11.02M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2014-06-30	Reported	(m)	-$13.49M	(m)	(m)	(m)	$248.00K	(m)	(m)	$9.57M	(m)	-$130.00K
2014-06-30	Rolling	(m)	-$13.49M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2014-03-31	Rolling	(m)	-$13.46M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2013-12-31	Rolling	(m)	-$14.05M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2013-09-30	Rolling	(m)	-$13.16M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2013-06-30	Reported	(m)	-$12.03M	(m)	(m)	(m)	$68.00K	-$8.74M	(m)	$7.00M	(m)	-$117.00K
2013-06-30	Rolling	(m)	-$12.03M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2013-03-31	Rolling	(m)	-$10.36M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2012-12-31	Rolling	(m)	-$10.28M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2012-09-30	Rolling	(m)	-$25.27M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2012-06-30	Reported	(m)	-$25.21M	(m)	(m)	(m)	$405.00K	-$9.00M	(m)	$7.04M	(m)	-$169.00K
2012-06-30	Rolling	(m)	-$25.21M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2012-03-31	Rolling	(m)	-$23.21M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2011-12-31	Rolling	(m)	-$23.62M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2011-09-30	Rolling	(m)	-$9.10M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2011-06-30	Reported	(m)	-$10.00M	(m)	(m)	(m)	$133.00K	-$3.17M	(m)	$6.86M	(m)	-$218.00K
2011-06-30	Rolling	(m)	-$10.00M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2010-06-30	Reported	(m)	$9.09M	(m)	(m)	(m)	$15.00K	$9.90M	(m)	$6.99M	(m)	$23.00K

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
908 Devices Inc. (MASS)	United States	$0.476B	-9.53
Quanterix Corp (QTRX)	United States	$0.150B	-1.65
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB)	United States	$0.491B	-3.95
Nautilus Biotechnology, Inc. (NAUT)	United States	$0.129B	-4.16
Seer, Inc. (SEER)	United States	$0.104B	-1.34
Precipio, Inc. (PRPO)	United States	$0.043B	-36.70
HARVARD BIOSCIENCE INC (HBIO)	United States	$0.037B	-2.70
Bionano Genomics, Inc. (BNGO)	United States	$0.020B	-0.42
ASTROTECH Corp (ASTC)	United States	$0.013B
Cytek Biosciences, Inc. (CTKB)	United States	$0.744B	-7.15